# Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor

> **NCT00921336** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 13 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** KW-2450

## Key facts

- **NCT ID:** NCT00921336
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00921336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00921336, "Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00921336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*